- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Trishan Panch Outlines the Larger Care Coordination Problem
The medication adherence problem is emblematic of the larger coordinated care issue in the US healthcare system, according to Trishan Panch, MBBS, MPH, chief medical officer at Wellframe.
While medication adherence seems, at the surface, like a fairly simple thing to do, there are barriers that prevent the patients who most need those medication from taking them, Trishan Panch, MBBS, MPH, chief medical officer at Wellframe, said at the Patient-Centered Diabetes Care meeting, co-hosted by The American Journal of Managed Care and Joslin Diabetes Center, April 16-17 in Boston.
He added that the medication adherence problem is emblematic of the larger coordinated care issue in the US healthcare system.
"We believe that you have to not just coordinate medication, you've got to coordinate visits, you've got to learn about the condition, you've got to test the understanding of that learning, screen for secondary complications of the condition, and manage risk factors underlying the specific disease," he explained.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
How FcRn Blockade Targets Myasthenia Gravis Autoantibodies
January 29th 2025In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent in treating adolescents who have the myasthenia gravis and how nipocalimab works via FcRn blockade to reduce the circulating autoantibodies that drive myasthenia gravis.
Read More
